US 12,122,799 B2
Antibiotics for veterinary staphylococcal infections
Cynthia Dowd, Washington, DC (US); Audrey Odom John, St. Louis, MO (US); Rachel Edwards, St. Louis, MO (US); Kenneth M. Heidel, Washington, DC (US); Xu Wang, Exton, PA (US); and Rene Chofor, Washington, DC (US)
Assigned to THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION, Washington, DC (US); and WASHINGTON UNIVERSITY, St. Louis, MO (US)
Appl. No. 17/253,841
Filed by THE GEORGE WASHINGTON UNIVERSITY, A CONGRESSIONALLY CHARTERED NOT-FOR-PROFIT CORPORATION, Washington, DC (US); and WASHINGTON UNIVERSITY, St. Louis, MO (US)
PCT Filed Jun. 18, 2019, PCT No. PCT/US2019/037761
§ 371(c)(1), (2) Date Dec. 18, 2020,
PCT Pub. No. WO2019/246119, PCT Pub. Date Dec. 26, 2019.
Claims priority of provisional application 62/686,416, filed on Jun. 18, 2018.
Prior Publication US 2021/0261580 A1, Aug. 26, 2021
Int. Cl. A61P 31/04 (2006.01); C07F 9/40 (2006.01)
CPC C07F 9/4015 (2013.01) [A61P 31/04 (2018.01); C07F 9/4009 (2013.01)] 5 Claims
 
1. A method for treating a Staphylococcal infection in a subject in need thereof, the method comprising administering to the subject an effective amount of a compound of Formula (XVIII):

OG Complex Work Unit Chemistry
or a pharmaceutically acceptable salt thereof, wherein POM is —CH2OC(═O)C(CH3)3.